
<!DOCTYPE html>
<html>
<meta charset="UTF-8">
<head>
  <title>Most Relevant Terms per Topic</title>

<style>
table {
  font-family: "Trebuchet MS", Arial, Helvetica, sans-serif;
  border-collapse: collapse;
  width: 100%;
}

td, th {
  border: 1px solid #ddd;
  padding: 8px;
}

td:nth-child(even){background-color: #f2f2f2;}

td:hover {background-color: #ddd;}

th {
  padding-top: 12px;
  padding-bottom: 12px;
  text-align: left;
  background-color: #0099FF;
  color: white;
}
</style>

</head>
<body>
<h2>Most Relevant Terms per Topic</h2>
<h3>Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 63</h3>
<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th><a href="Topic_01.html" target="_blank">Topic 1</a></th>
      <th><a href="Topic_02.html" target="_blank">Topic 2</a></th>
      <th><a href="Topic_03.html" target="_blank">Topic 3</a></th>
      <th><a href="Topic_04.html" target="_blank">Topic 4</a></th>
      <th><a href="Topic_05.html" target="_blank">Topic 5</a></th>
      <th><a href="Topic_06.html" target="_blank">Topic 6</a></th>
      <th><a href="Topic_07.html" target="_blank">Topic 7</a></th>
      <th><a href="Topic_08.html" target="_blank">Topic 8</a></th>
      <th><a href="Topic_09.html" target="_blank">Topic 9</a></th>
      <th><a href="Topic_10.html" target="_blank">Topic 10</a></th>
      <th><a href="Topic_11.html" target="_blank">Topic 11</a></th>
      <th><a href="Topic_12.html" target="_blank">Topic 12</a></th>
      <th><a href="Topic_13.html" target="_blank">Topic 13</a></th>
      <th><a href="Topic_14.html" target="_blank">Topic 14</a></th>
      <th><a href="Topic_15.html" target="_blank">Topic 15</a></th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>1</th>
      <td>%</td>
      <td>infections</td>
      <td>lung</td>
      <td>HSCT</td>
      <td>women</td>
      <td>RVI</td>
      <td>GVHD</td>
      <td>expression</td>
      <td>BAL</td>
      <td>preterm</td>
      <td>donor</td>
      <td>pneumocystis</td>
      <td>NEC</td>
      <td>oct4</td>
      <td>IA</td>
    </tr>
    <tr>
      <th>2</th>
      <td>patients</td>
      <td>viral</td>
      <td>lung transplantation</td>
      <td>stem</td>
      <td>pregnancy</td>
      <td>respiratory</td>
      <td>engraftment</td>
      <td>cancer</td>
      <td>CMV</td>
      <td>birth</td>
      <td>donors</td>
      <td>pneumonia</td>
      <td>infants</td>
      <td>corneal</td>
      <td>agvhd</td>
    </tr>
    <tr>
      <th>3</th>
      <td>=</td>
      <td>infection</td>
      <td>rejection</td>
      <td>deficiency</td>
      <td>pregnant</td>
      <td>tract</td>
      <td>TBI</td>
      <td>eif3f</td>
      <td>bronchoalveolar</td>
      <td>inflammation</td>
      <td>kidney</td>
      <td>pancreatic</td>
      <td>surgery</td>
      <td>cancer</td>
      <td>response</td>
    </tr>
    <tr>
      <th>4</th>
      <td>median</td>
      <td>immune</td>
      <td>pulmonary</td>
      <td>immunodeficiency</td>
      <td>maternal</td>
      <td>virus</td>
      <td>alemtuzumab</td>
      <td>CXCL14</td>
      <td>allo‐hsct</td>
      <td>AF</td>
      <td>heart</td>
      <td>pneumocystis pneumonia</td>
      <td>visits</td>
      <td>removal</td>
      <td>htrs</td>
    </tr>
    <tr>
      <th>5</th>
      <td>CI</td>
      <td>infectious</td>
      <td>bronchiolitis</td>
      <td>cell</td>
      <td>pregnant women</td>
      <td>CARV</td>
      <td>+</td>
      <td>GC</td>
      <td>lavage</td>
      <td>preterm birth</td>
      <td>mice</td>
      <td>biopsy</td>
      <td>pandemic</td>
      <td>cells</td>
      <td>ioaes</td>
    </tr>
    <tr>
      <th>6</th>
      <td>95</td>
      <td>transplant</td>
      <td>dysfunction</td>
      <td>SCID</td>
      <td>delivery</td>
      <td>RSV</td>
      <td>EBV</td>
      <td>colorectal</td>
      <td>fluid</td>
      <td>MR</td>
      <td>transplantation</td>
      <td>R-CHOP</td>
      <td>ACDMPV</td>
      <td>esophageal</td>
      <td>stent</td>
    </tr>
    <tr>
      <th>7</th>
      <td>study</td>
      <td>mortality</td>
      <td>allograft</td>
      <td>hematopoietic stem cell transplantation</td>
      <td>placental</td>
      <td>HCT</td>
      <td>gvhd</td>
      <td>FGL2</td>
      <td>infiltrates</td>
      <td>PCR/ESI-MS</td>
      <td>organ</td>
      <td>PCP</td>
      <td>abnormal</td>
      <td>esophageal cancer</td>
      <td>HLH</td>
    </tr>
    <tr>
      <th>8</th>
      <td>incidence</td>
      <td>viruses</td>
      <td>obliterans</td>
      <td>autologous</td>
      <td>fetal</td>
      <td>syncytial</td>
      <td>ATG</td>
      <td>adenocarcinoma</td>
      <td>pulmonary</td>
      <td>intra-amniotic</td>
      <td>skin</td>
      <td>PJP</td>
      <td>ER</td>
      <td>port</td>
      <td>micafungin</td>
    </tr>
    <tr>
      <th>9</th>
      <td>days</td>
      <td>viral infections</td>
      <td>lung transplant</td>
      <td>recurrent</td>
      <td>cesarean</td>
      <td>LRTD</td>
      <td>t-cell</td>
      <td>carcinoma</td>
      <td>pulmonary infiltrates</td>
      <td>births</td>
      <td>alloantibody</td>
      <td>FCR</td>
      <td>transfusion</td>
      <td>prostate</td>
      <td>fenestrated</td>
    </tr>
    <tr>
      <th>10</th>
      <td>METHODS</td>
      <td>risk</td>
      <td>acute</td>
      <td>severe</td>
      <td>SARS</td>
      <td>respiratory syncytial virus</td>
      <td>irradiation</td>
      <td>cancers</td>
      <td>PCR</td>
      <td>score</td>
      <td>donation</td>
      <td>lymphoma</td>
      <td>enterocolitis</td>
      <td>TIVAP</td>
      <td>second-line</td>
    </tr>
    <tr>
      <th>11</th>
      <td>rate</td>
      <td>solid</td>
      <td>BOS</td>
      <td>patient</td>
      <td>placentas</td>
      <td>IPS</td>
      <td>dogs</td>
      <td>BCRP</td>
      <td>RVP‐PCR</td>
      <td>amniotic</td>
      <td>kidney transplant</td>
      <td>jirovecii</td>
      <td>prematurity</td>
      <td>pluripotency</td>
      <td>branched</td>
    </tr>
    <tr>
      <th>12</th>
      <td>disease</td>
      <td>morbidity</td>
      <td>CLAD</td>
      <td>marrow</td>
      <td>COVID-19</td>
      <td>influenza</td>
      <td>relapse</td>
      <td>LC-CD133(+</td>
      <td>bronchoalveolar lavage</td>
      <td>mr score</td>
      <td>CD26(–/–</td>
      <td>non-hodgkin</td>
      <td>'s</td>
      <td>radiation</td>
      <td>antifungal</td>
    </tr>
    <tr>
      <th>13</th>
      <td>RESULTS</td>
      <td>fungal</td>
      <td>acute rejection</td>
      <td>bone</td>
      <td>ZIKV</td>
      <td>LRTI</td>
      <td>gy</td>
      <td>lung adenocarcinoma</td>
      <td>DNA</td>
      <td>gestational</td>
      <td>metagenomic</td>
      <td>non-hodgkin lymphoma</td>
      <td>necrotizing</td>
      <td>PDIS</td>
      <td>caspofungin</td>
    </tr>
    <tr>
      <th>14</th>
      <td>6</td>
      <td>pathogens</td>
      <td>syndrome</td>
      <td>allogeneic</td>
      <td>mother</td>
      <td>respiratory tract infection</td>
      <td>body</td>
      <td>tumor</td>
      <td>testing</td>
      <td>PROM</td>
      <td>organ transplantation</td>
      <td>PCNSL</td>
      <td>atypical</td>
      <td>port infection</td>
      <td>etanercept</td>
    </tr>
    <tr>
      <th>15</th>
      <td>occurred</td>
      <td>bacterial</td>
      <td>bronchiolitis obliterans syndrome</td>
      <td>report</td>
      <td>fetus</td>
      <td>upper</td>
      <td>i.v</td>
      <td>cervical</td>
      <td>LOSP</td>
      <td>intra-amniotic inflammation</td>
      <td>liver</td>
      <td>CAP</td>
      <td>united</td>
      <td>embryonic</td>
      <td>partial</td>
    </tr>
    <tr>
      <th>16</th>
      <td>analysis</td>
      <td>organ</td>
      <td>chronic</td>
      <td>genetic</td>
      <td>intrauterine</td>
      <td>parainfluenza</td>
      <td>total body irradiation</td>
      <td>PRSS</td>
      <td>copies/ml</td>
      <td>SPB</td>
      <td>transplanted</td>
      <td>surgical</td>
      <td>CM</td>
      <td>CTC</td>
      <td>ECP</td>
    </tr>
    <tr>
      <th>17</th>
      <td>underwent</td>
      <td>strategies</td>
      <td>noninfectious</td>
      <td>successful</td>
      <td>published</td>
      <td>RV</td>
      <td>serotherapy</td>
      <td>lung cancer</td>
      <td>pneumonia</td>
      <td>prevalence</td>
      <td>cytokines</td>
      <td>cohort</td>
      <td>healthcare</td>
      <td>prostate cancer</td>
      <td>mold infections</td>
    </tr>
    <tr>
      <th>18</th>
      <td>months</td>
      <td>recipients</td>
      <td>transplantation</td>
      <td>stem cell</td>
      <td>perinatal</td>
      <td>allo-lss</td>
      <td>haploidentical</td>
      <td>genotype</td>
      <td>diagnostic</td>
      <td>preterm prom</td>
      <td>sensitized</td>
      <td>biopsies</td>
      <td>decitabine</td>
      <td>water</td>
      <td>mold</td>
    </tr>
    <tr>
      <th>19</th>
      <td>BACKGROUND</td>
      <td>opportunistic</td>
      <td>idiopathic</td>
      <td>includes</td>
      <td>labor</td>
      <td>lower</td>
      <td>controls</td>
      <td>SSTR2</td>
      <td>microbiologic</td>
      <td>preterm infants</td>
      <td>ascs</td>
      <td>pancreatic biopsy</td>
      <td>CHD</td>
      <td>corneal perforation</td>
      <td>scans</td>
    </tr>
    <tr>
      <th>20</th>
      <td>retrospective</td>
      <td>population</td>
      <td>important</td>
      <td>mutations</td>
      <td>covid-19 pneumonia</td>
      <td>IFD</td>
      <td>low-dose</td>
      <td>cetuximab</td>
      <td>yield</td>
      <td>frequency</td>
      <td>jcpyv</td>
      <td>hematological cancer</td>
      <td>necrotizing enterocolitis</td>
      <td>ipscs</td>
      <td>PAP</td>
    </tr>
    <tr>
      <th>21</th>
      <td>12</td>
      <td>common</td>
      <td>AMR</td>
      <td>indications</td>
      <td>trimester</td>
      <td>PIV</td>
      <td>cmv disease</td>
      <td>POP</td>
      <td>load</td>
      <td>chorioamnionitis</td>
      <td>cytokine</td>
      <td>absolute</td>
      <td>nno</td>
      <td>preferred</td>
      <td>antifungal therapy</td>
    </tr>
    <tr>
      <th>22</th>
      <td>1</td>
      <td>respiratory viruses</td>
      <td>CBO</td>
      <td>failure</td>
      <td>preterm delivery</td>
      <td>carvs</td>
      <td>subq</td>
      <td>marker</td>
      <td>specimens</td>
      <td>RNA</td>
      <td>transmission</td>
      <td>count</td>
      <td>older</td>
      <td>radiation oncologist</td>
      <td>responders</td>
    </tr>
    <tr>
      <th>23</th>
      <td>compared</td>
      <td>immunocompromised</td>
      <td>early</td>
      <td>combined</td>
      <td>congenital</td>
      <td>hdct/auto-sct</td>
      <td>ptcy</td>
      <td>levels</td>
      <td>bronchoscopy</td>
      <td>mass</td>
      <td>recipient</td>
      <td>AIDS</td>
      <td>AML</td>
      <td>oncologist</td>
      <td>72</td>
    </tr>
    <tr>
      <th>24</th>
      <td><</td>
      <td>prevention</td>
      <td>LB</td>
      <td>preventing</td>
      <td>ribavirin</td>
      <td>RBV</td>
      <td>days</td>
      <td>carriers</td>
      <td>NP</td>
      <td>amniotic fluid</td>
      <td>screening</td>
      <td>NHL</td>
      <td>full-term</td>
      <td>perforation</td>
      <td>P<0.01</td>
    </tr>
    <tr>
      <th>25</th>
      <td>CONCLUSIONS</td>
      <td>treatment</td>
      <td>mechanisms</td>
      <td>guidelines</td>
      <td>delivered</td>
      <td>ratio</td>
      <td>immunosuppression</td>
      <td>cervical cancer</td>
      <td>VL</td>
      <td>gestational age</td>
      <td>current</td>
      <td>immunocompromise</td>
      <td>united states</td>
      <td>somatic</td>
      <td>treatment</td>
    </tr>
    <tr>
      <th>26</th>
      <td>7</td>
      <td>viral infection</td>
      <td>idiopathic pneumonia syndrome</td>
      <td>hematopoietic</td>
      <td>observed</td>
      <td>models</td>
      <td>chimerism</td>
      <td>TNBC</td>
      <td>FB</td>
      <td>weeks</td>
      <td>extensive</td>
      <td>ASCT</td>
      <td>ectopic</td>
      <td>bipscs</td>
      <td>asymptomatic</td>
    </tr>
    <tr>
      <th>27</th>
      <td>CONCLUSION</td>
      <td>complications</td>
      <td>chronic lung allograft dysfunction</td>
      <td>IKBKB</td>
      <td>distress</td>
      <td>knowledge</td>
      <td>donor</td>
      <td>oct-4</td>
      <td>predictive</td>
      <td>BPD</td>
      <td>reduced</td>
      <td>2-year</td>
      <td>states</td>
      <td>maintaining</td>
      <td>therapy</td>
    </tr>
    <tr>
      <th>28</th>
      <td>100</td>
      <td>regimens</td>
      <td>recipients</td>
      <td>immune deficiency</td>
      <td>elective</td>
      <td>odds ratio</td>
      <td>dose</td>
      <td>adjacent</td>
      <td>diagnosis</td>
      <td>CS</td>
      <td>donor screening</td>
      <td>aplastic</td>
      <td>infection‐related</td>
      <td>embryonic stem cells</td>
      <td>CT</td>
    </tr>
    <tr>
      <th>29</th>
      <td>30</td>
      <td>bacteria</td>
      <td>injury</td>
      <td>working</td>
      <td>respiratory distress syndrome</td>
      <td>allo-ls</td>
      <td>cyclosporine</td>
      <td>DFS</td>
      <td>AHSCT</td>
      <td>cultivation</td>
      <td>CD26(+/+</td>
      <td>lung biopsy</td>
      <td>assessments</td>
      <td>rivers</td>
      <td>HR</td>
    </tr>
    <tr>
      <th>30</th>
      <td>significant</td>
      <td>including</td>
      <td>major</td>
      <td>CID</td>
      <td>hcs</td>
      <td>respiratory virus</td>
      <td>TTV</td>
      <td>her‐2/neu</td>
      <td>bronchial</td>
      <td>preterm births</td>
      <td>CD26</td>
      <td>2007</td>
      <td>non-htx</td>
      <td>HCV</td>
      <td>immunosuppressive drugs</td>
    </tr>
    <tr>
      <th>31</th>
      <td>versus</td>
      <td>transplantation</td>
      <td>exosomes</td>
      <td>thrombocytopenia</td>
      <td>vaginal</td>
      <td>vris</td>
      <td>CD3</td>
      <td>resistance</td>
      <td>positive</td>
      <td>early-onset</td>
      <td>non-sensitized</td>
      <td>HCT</td>
      <td>neonatal</td>
      <td>item</td>
      <td>aortic</td>
    </tr>
    <tr>
      <th>32</th>
      <td>associated with</td>
      <td>therapy</td>
      <td>lung allograft</td>
      <td>ICF</td>
      <td>vertical transmission</td>
      <td>60-day</td>
      <td>depleted</td>
      <td>migration</td>
      <td>washing</td>
      <td>samples</td>
      <td>spleen</td>
      <td>users</td>
      <td>neonates</td>
      <td>pluripotent</td>
      <td>voriconazole</td>
    </tr>
    <tr>
      <th>33</th>
      <td>vs.</td>
      <td>factors</td>
      <td>lung injury</td>
      <td>ois</td>
      <td>newborns</td>
      <td>adenovirus</td>
      <td>doses</td>
      <td>breast</td>
      <td>iu/ml</td>
      <td>tests</td>
      <td>mpbls</td>
      <td>authorized</td>
      <td>miscarriage</td>
      <td>lakes</td>
      <td>haplo‐sct</td>
    </tr>
    <tr>
      <th>34</th>
      <td>2</td>
      <td>life</td>
      <td>increasingly</td>
      <td>ADA</td>
      <td>vertical</td>
      <td>transplant</td>
      <td>graft-versus-host</td>
      <td>correlated</td>
      <td>rvp‐pcr testing</td>
      <td>spontaneous</td>
      <td>anti-donor</td>
      <td>online version</td>
      <td>added</td>
      <td>tarsorrhaphy</td>
      <td>allo-ric</td>
    </tr>
    <tr>
      <th>35</th>
      <td>results</td>
      <td>patients</td>
      <td>bronchiolitis obliterans</td>
      <td>comorbidities</td>
      <td>transmission</td>
      <td>infection</td>
      <td>grafts</td>
      <td>recurrence</td>
      <td>cmv pneumonia</td>
      <td>plasma samples</td>
      <td>kidney transplantation</td>
      <td>version</td>
      <td>EPAC</td>
      <td>0.0001</td>
      <td>nonresponders</td>
    </tr>
    <tr>
      <th>36</th>
      <td>allogeneic</td>
      <td>solid organ transplant</td>
      <td>histopathologic</td>
      <td>blood</td>
      <td>neonatal</td>
      <td>detection</td>
      <td>dla-identical</td>
      <td>prognosis</td>
      <td>diagnostic yield</td>
      <td>bronchopulmonary dysplasia</td>
      <td>donations</td>
      <td>supplementary</td>
      <td>formula</td>
      <td>framework</td>
      <td>cgvhd</td>
    </tr>
    <tr>
      <th>37</th>
      <td>survival</td>
      <td>suppression</td>
      <td>complications</td>
      <td>diseases</td>
      <td>mode</td>
      <td>coronavirus</td>
      <td>viremia</td>
      <td>EVT</td>
      <td>100‐day</td>
      <td>microbial-associated</td>
      <td>secreting</td>
      <td>89.6</td>
      <td>avoidance</td>
      <td>mscs</td>
      <td>half</td>
    </tr>
    <tr>
      <th>38</th>
      <td>interval</td>
      <td>affecting</td>
      <td>development</td>
      <td>delay</td>
      <td>exposed</td>
      <td>.01</td>
      <td>CR</td>
      <td>negatively</td>
      <td>survival rate</td>
      <td>perinatal mortality</td>
      <td>UCB</td>
      <td>cosavirus</td>
      <td>gram‐negative</td>
      <td>regraft</td>
      <td>grafting</td>
    </tr>
    <tr>
      <th>39</th>
      <td>OS</td>
      <td>cell</td>
      <td>BO</td>
      <td>MIRAGE</td>
      <td>third trimester</td>
      <td>metapneumovirus</td>
      <td>weeks</td>
      <td>colorectal carcinoma</td>
      <td>AGA</td>
      <td>proteomic</td>
      <td>antigen‐specific</td>
      <td>online</td>
      <td>CD</td>
      <td>applied</td>
      <td>first-line therapy</td>
    </tr>
    <tr>
      <th>40</th>
      <td>24</td>
      <td>donor-derived</td>
      <td>costimulatory</td>
      <td>stem cell transplantation</td>
      <td>2019</td>
      <td>ISI</td>
      <td>graft</td>
      <td>MGT</td>
      <td>SCT</td>
      <td>ionization</td>
      <td>igg</td>
      <td>prevalences</td>
      <td>feeding</td>
      <td>scs</td>
      <td>intraoperative</td>
    </tr>
    <tr>
      <th>41</th>
      <td>28</td>
      <td>infectious complications</td>
      <td>alloimmune</td>
      <td>engrafted</td>
      <td>severe</td>
      <td>all-cause</td>
      <td>marrow</td>
      <td>polymorphisms</td>
      <td>cut-off</td>
      <td>sterile</td>
      <td>serum</td>
      <td>cats</td>
      <td>emergency</td>
      <td>M1</td>
      <td>ct scans</td>
    </tr>
    <tr>
      <th>42</th>
      <td>clinical</td>
      <td>drug</td>
      <td>organizing</td>
      <td>curative therapy</td>
      <td>syndrome</td>
      <td>year</td>
      <td>received</td>
      <td>breast cancer</td>
      <td>BALF</td>
      <td>burden</td>
      <td>graft rejection</td>
      <td>SUPPLEMENTARY</td>
      <td>post-epac</td>
      <td>self-renewal</td>
      <td>efficacy</td>
    </tr>
    <tr>
      <th>43</th>
      <td>odds</td>
      <td>disease</td>
      <td>forced</td>
      <td>homozygous</td>
      <td>placenta</td>
      <td>human metapneumovirus</td>
      <td>infusion-related</td>
      <td>CD133</td>
      <td>allogeneic hematopoietic stem cell transplant</td>
      <td>adverse pregnancy</td>
      <td>collected</td>
      <td>SCNSL</td>
      <td>reassessments</td>
      <td>mesenchymal</td>
      <td>phase</td>
    </tr>
    <tr>
      <th>44</th>
      <td>difference</td>
      <td>stem</td>
      <td>LTR</td>
      <td>syndrome</td>
      <td>malformations</td>
      <td>upper respiratory tract infection</td>
      <td>tacrolimus</td>
      <td>plays</td>
      <td>qrt-pcr</td>
      <td>perinatal</td>
      <td>rejection</td>
      <td>receiving</td>
      <td>postoperative</td>
      <td>calibrated</td>
      <td>GVHD</td>
    </tr>
    <tr>
      <th>45</th>
      <td>enrolled</td>
      <td>community-acquired</td>
      <td>DSA</td>
      <td>clinical</td>
      <td>cesarean delivery</td>
      <td>predictor</td>
      <td>mycophenolate</td>
      <td>AURKA</td>
      <td>performed</td>
      <td>age</td>
      <td>transplant</td>
      <td>cases</td>
      <td>hemorrhage</td>
      <td>HM</td>
      <td>15</td>
    </tr>
    <tr>
      <th>46</th>
      <td>31</td>
      <td>broad</td>
      <td>clinical presentation</td>
      <td>cells</td>
      <td>hiv-1-infected</td>
      <td>allo‐hsct recipients</td>
      <td>renal transplant</td>
      <td>epitopes</td>
      <td>pulmonary infiltrate</td>
      <td>infants</td>
      <td>graft</td>
      <td>PD</td>
      <td>low</td>
      <td>tumor</td>
      <td>non-responders</td>
    </tr>
    <tr>
      <th>47</th>
      <td>complications</td>
      <td>donor-derived infections</td>
      <td>ltx</td>
      <td>cases</td>
      <td>unborn</td>
      <td>recipients</td>
      <td>dlis</td>
      <td>cancer surgery</td>
      <td>dna loads</td>
      <td>MIAC</td>
      <td>alloab</td>
      <td>.008</td>
      <td>7.4</td>
      <td>adult</td>
      <td>aneurysms</td>
    </tr>
    <tr>
      <th>48</th>
      <td>adjusted</td>
      <td>immune suppression</td>
      <td>molecule</td>
      <td>post-hsct</td>
      <td>congenital malformations</td>
      <td>children</td>
      <td>dog</td>
      <td>cells</td>
      <td>deleterious</td>
      <td>STB</td>
      <td>disease transmission</td>
      <td>postmortem</td>
      <td>incurred</td>
      <td>conclusion</td>
      <td>2/13</td>
    </tr>
    <tr>
      <th>49</th>
      <td>TRM</td>
      <td>hematopoietic</td>
      <td>expiratory</td>
      <td>starting</td>
      <td>nonelective</td>
      <td>associated with</td>
      <td>conditioned</td>
      <td>significantly</td>
      <td>polymerase chain reaction</td>
      <td>ge/well</td>
      <td>complexity</td>
      <td>pancreatitis</td>
      <td>deferred</td>
      <td>white blood cell</td>
      <td>combination</td>
    </tr>
    <tr>
      <th>50</th>
      <td>cell</td>
      <td>epidemiology</td>
      <td>supportive</td>
      <td>*</td>
      <td>intrauterine growth restriction</td>
      <td>hematopoietic</td>
      <td>mg/kg</td>
      <td>normal</td>
      <td>dna load</td>
      <td>electrospray ionization mass spectrometry</td>
      <td>musculoskeletal</td>
      <td>pathogen(s</td>
      <td>ciliary</td>
      <td>embryonic-like</td>
      <td>screening</td>
    </tr>
  </tbody>
</table>
</body>
</html>
